Ascl2 knockdown in CRC cells led to significant increases in the levels of goblet cell differentiation markers, including MUC2 and TFF3, and to marked increases in CDX2 mRNA and protein expression. This evidence concerns the gene ASCL2 and colorectal carcinoma.